Viewing Study NCT03602560

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 2:06 AM

Ignite Modification Date: 2026-01-26 @ 4:15 AM

Study NCT ID: NCT03602560

Status: COMPLETED

Last Update Posted: 2022-08-02

First Post: 2018-07-18

Is Gene Therapy: True

Has Adverse Events: True

Brief Title: ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)

Sponsor: Gilead Sciences

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module